International guidelines recommend RRSO after completion of childbearing or at 35–40 years of age for BRCA1 mutations carriers or at 40–55 years of age for BRCA2 mutation carriers to reduce the risk of breast and ovarian cancers. This evidence concerns the gene BRCA2 and ovarian carcinoma.